Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
- 31 January 2012
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 13 (1), e11-e22
- https://doi.org/10.1016/s1470-2045(11)70175-9
Abstract
No abstract availableThis publication has 98 references indexed in Scilit:
- What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?Liver Transplantation, 2011
- Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinomaLiver Transplantation, 2011
- New Strategies in Hepatocellular Carcinoma: Genomic Prognostic MarkersClinical Cancer Research, 2010
- Sorafenib for Recurrent Hepatocellular Carcinoma After Liver TransplantationJapanese Journal of Clinical Oncology, 2010
- Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients databaseJournal of Hepatology, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Grading quality of evidence and strength of recommendations for diagnostic tests and strategiesBMJ, 2008
- Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver TransplantationAmerican Journal of Transplantation, 2007
- Does Microvascular Invasion Affect Outcomes After Liver Transplantation for HCC? A Histopathological Analysis of 155 Consecutive ExplantsJournal of Gastrointestinal Surgery, 2007
- Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)The Esophagus, 2003